Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program

April 15

Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program

People who inject drugs (PWID) represent approximately 90% of newly acquired hepatitis C (HCV) infections. Clinicians working with PWID play an important role in reducing HCV-related morbidity and mortality through early diagnosis and treatment. With the advent of new, well-tolerated, short-course direct-acting antiviral (DAA) HCV regimens with cure rates >95%, there is an opportunity to vastly improve the health outcomes of people living with HCV.

This program is designed for addiction medicine specialists, OST prescribers, family physicians and other medical
staff working with people who inject drugs. Through online learning and a face-to-face workshop, delivered by
local experts, participants will gain the skills to confidently manage hepatitis C in their setting.

Upon completion of this program, participants will be able to:

  • Describe the risk factors for HCV infection, enabling effective practice screening processes and prevention education
  • Demonstrate competence interpreting clinical information to effectively diagnose HCV
  • Demonstrate competence in liver disease assessment
  • Demonstrate an understanding of DAA therapy for the treatment of HCV and competence in selecting and prescribing appropriate therapy
  • Monitor patients on treatment and post-treatment appropriately

Date: Sunday, 27 October 2019

Time: 8:30am – 4:00pm

Location: Halifax Marriott Harbourfront Hotel – 1919 Upper Water Street, Halifax Canada, B3J 3J5

Cost: Free of charge, catering provided. Places are limited – registration is essential.

Register link: https://ashm.eventsair.com/halifax-27-oct-2019/registration/Site/Register

Register before: Thursday, 17 October 2019

More information: For further details contact education@ashm.org.au

Open to both delegates from the CSAM Meeting and local practitioners. For further information or to inquire about travel scholarships, please contact education@ashm.org.au

This Group Learning program has also been reviewed by the College of Family Physicians of Canada and is awaiting final certification by the College’s BC Chapter.

The Symposium is convened by the International Network on Hepatitis in Substance Users (INHSU), an international organization dedicated to scientific knowledge exchange, knowledge translation, and advocacy focused on hepatitis C prevention and care among people who use drugs. 

This workshop has been funded through an unrestricted grant from AbbVie Canada and Gilead Sciences Canada. AbbVie and Gilead have had no input into the tone, content or emphasis of the material used at this course

Download Flyer


Posted in: News

« Previous PostNext Post »
Suggest a News Item